MedTrace Logo

Rheum@Home: RA Remote Patient Monitoring

NCT05725577 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-11-25

No results posted yet for this study

Summary

The goal of this pragmatic multicentre clinical trial is to investigate whether telemonitoring with Rheum@Home leads to less outpatient visits, while maintaining tight disease control and high patient-experienced quality of care in patients with rheumatoid arthritis.

Participants will be asked to

* complete questionaires every 4 weeks
* perform a walking test every 4 weeks
* routine lab
* routine disease activity measurement by a qualified assessor

Researchers will compare care via the telemedicine system (intervention) or standard care (control) to see if there are differences in the number of rheumatology outpatient visits and patient reported quality of care after 12 months follow up.

Conditions

Interventions

OTHER

care via the telemedicine system

Care via the telemedicine system

OTHER

Routine care

Routine care

Sponsors & Collaborators

  • University of Twente

    collaborator OTHER

  • Reade Rheumatology Research Institute

    collaborator OTHER

  • Maastricht University Medical Center

    collaborator OTHER

  • Medisch Spectrum Twente

    lead OTHER

Principal Investigators

  • Harald Vonkeman, MD · University of Twente

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2023-06-01
Completion
2023-06-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05725577 on ClinicalTrials.gov